Telomere length and vascular wall in patients with Type 2 Diabetes Mellitus

Aim.
To study the relationship between changes in the artery structure and function and peripheral lymphocyte telomere length in patients with type 2 diabetes mellitus (DM2).
Materials and methods.
A total of 50 patients with T2DM and without clinical manifestations of cardiovascular disease (CVD) were included in the study; the control group consisted of 49 people. The following tests were conducted for all study participants: carbohydrate metabolism evaluation, carotid artery duplex scan to measure intima?media complex thickness (IMT) and to determine the presence of atherosclerotic plaques, carotid?femoral pulse wave velocity (PWV) measurement and lymphocyte telomere length measurement.
Results.
The vascular changes were more pronounced in patients with T2DM than in controls. The telomeres were shorter in patients with T2DM than in those without diabetes (9.53?0.1 vs 9.86?0.1, p=0.033). The participants were divided according to the telomere length. Among patients with T2DM, there were significant differences in the condition of the vascular wall [PWV: 10.58?0.1 m/s in patients with ?long? telomeres and 15.08?1.3 m/s in patients with ?short? telomeres; IMT: 0.80?0.09 mm in patients with ?long? telomeres and 0.87?0.05 mm in patients with ?short? telomeres (p=0.024)]. There were no significant differences in the arterial structure between the patient and control groups with ?long? telomeres [PWV: 10.58?0.1 m/s vs 10.5?0.5 m/s (p=0.913); IMT: 0.080?0.09 mm vs 0.73?0.03 mm (p=0.12). However, there were significant differences in the vascular wall condition between the patient and control groups with ?short? telomeres [PWV: 15.08?1.3 m/s vs, 10.7?0.5 m/s (p=0.015); IMT: 0.87?0.1 vs 0.78?0.1 (p=0.03)].
Conclusions.
The signs of vascular ageing were more pronounced in patients with T2DM than in controls. However, despite diabetes, vascular changes were minimal in patients with ?long? lymphocyte telomeres, comparable with the state of the vascular walls in healthy individuals. Thus, enhanced lymphocyte telomere length may have a protective effect on the vascular wall and may prevent damage from carbohydrate metabolism disorders.

telomere length, vascular aging, diabetes mellitus, insulin resistance

1. Nilsson PM, Boutouyrie P, Cunha P, Kotsis V, Narkiewicz K, Parati G, et al. Early vascular ageing in translation: from laboratory investigations to clinical applications in cardiovascular prevention. Journal of Hypertension 2013;31(8):1517-1526. Available from: http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00004872-201308000-00003 PubMed PMID: 23743805. doi: 10.1097/HJH.0b013e328361e4bd

2. Strazhesko ID, Akasheva DU, Dudinskaya EN, Tkacheva ON. Vascular ageing: main symptoms and mechanisms. Cardiovascular Therapy and Prevention 2012;11(4):93-100.

3. Scuteri A, Najjar SS, Muller DC, Andres R, Hougaku H, Metter EJ, et al. Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness. J Am Coll Cardiol 2004;43(8):1388-1395. Available from: http://linkinghub.elsevier.com/retrieve/pii/S073510970400169X PubMed PMID: 15093872. doi: 10.1016/j.jacc.2003.10.061

4. Facchini FS, Hua N, Abbasi F, Reaven GM. Insulin resistance as a predictor of age-related diseases.. J Clin Endocrinol Metab 2001;86(8):3574-3578. Available from: http://toxnet.nlm.nih.gov/cgi-bin/sis/search/r?dbs+hsdb:@term+@rn+57-88-5 PubMed PMID: 11502781. doi: 10.1210/jcem.86.8.7763

5. Lilitkarntakul P, Dhaun N, Melville V, Kerr D, Webb DJ, Goddard J. Risk Factors for Metabolic Syndrome Independently Predict Arterial Stiffness and Endothelial Dysfunction in Patients With Chronic Kidney Disease and Minimal Comorbidity. Diabetes Care 2012;35(8):1774-1780. Available from: http://care.diabetesjournals.org/cgi/doi/10.2337/dc11-2345 PubMed PMID: 22648437. doi: 10.2337/dc11-2345

6. Gardner JP, Li S, Srinivasan SR, Chen W, Kimura M, Lu X, et al. Rise in insulin resistance is associated with escalated telomere attrition.. Circulation 2005;111(17):2171-2177. Available from: http://circ.ahajournals.org/cgi/pmidlookup?view=long&pmid=15851602 PubMed PMID: 15851602. doi: 10.1161/01.CIR.0000163550.70487.0B

7. Бойцов СА, Стражеско ИД, Акашева ДУ, Дудинская ЕН, Кругликова АС, Ткачева ОН. Инсулинорезистентность: благо или зло? механизмы развития и связь с возраст-ассоциированными изменениями сосудов. Кардиоваскулярная терапия и профилактика. 2013;12(4):91-97. [ Boytsov SA, Strazhesko ID, Akasheva DU, Dudinskaya EN, Kruglikova AS, Tkacheva ON. Insulin resistance: good or bad? Development mechanisms and the association with age-related vascular changes. Cardiovascular Therapy and Prevention. 2013;12(4):91-97.]

8. Samani NJ, Boultby R, Butler R, Thompson JR, Goodall AH. Telomere shortening in atherosclerosis. The Lancet. 2001;358(9280):472-473. doi: 10.1016/S0140-6736(01)05633-1

9. Benetos A, Gardner JP, Zureik M, Labat C, Xiaobin L, Adamopoulos C, et al. Short telomeres are associated with increased carotid atherosclerosis in hypertensive subjects. Hypertension. 2004;43(2):182-185. doi: 10.1161/01.HYP.0000113081.42868.f4

10. Blackburn EH, Greider CW, Szostak JW. Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging. Nat Med. 2006;12(10):1133-1138. doi: 10.1038/nm1006-1133

11. Daniali L, Benetos A, Susser E, Kark JD, Labat C, Kimura M, et al. Telomeres shorten at equivalent rates in somatic tissues of adults. Nat Commun. 2013;4:1597. doi: 10.1038/ncomms2602

12. Aviv A. Telomeres and human aging: facts and fibs. Sci Aging Knowledge Environ. 2004;2004(51):pe43. doi: 10.1126/sageke.2004.51.pe43

13. Murillo-Ortiz B, Albarrán-Tamayo F, Arenas-Aranda D, Benítez-Bribiesca L, Malacara-Hernández JM, Martínez-Garza S, et al. Telomere length and type 2 diabetes in males: a premature aging syndrome. Aging Male. 2012;15(1):54-58. doi: 10.3109/13685538.2011.593658

14. Mulder H. Is shortening of telomeres the missing link between aging and the Type 2 Diabetes epidemic? Aging (Albany NY). 2010;2(10):634-636.

15. Jeanclos E, Krolewski A, Skurnick J, Kimura M, Aviv H, Warram JH, et al. Shortened telomere length in white blood cells of patients with IDDM. Diabetes. 1998;47(3):482-286. doi: 10.2337/diabetes.47.3.482

16. Hovatta I, de Mello VD, Kananen L, Lindström J, Eriksson JG, Ilanne-Parikka P, et al. Leukocyte telomere length in the Finnish Diabetes Prevention Study. PLoS ONE. 2012;7(4):e34948. doi: 10.1371/journal.pone.0034948

17. Shah AS, Dolan LM, Kimball TR, Gao Z, Khoury PR, Daniels SR, et al. Influence of duration of diabetes, glycemic control, and traditional cardiovascular risk factors on early atherosclerotic vascular changes in adolescents and young adults with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2009;94(10):3740-3745. doi: 10.1210/jc.2008-2039

18. Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res. 2002;30(10):e47. doi: 10.1093/nar/30.10.e47

19. Sell DR, Monnier VM. Molecular basis of arterial stiffening: role of glycation - a mini-review. Gerontology. 2012; 58(3):227-237. doi: 10.1159/000334668

20. Sharpless NE, DePinho RA. How stem cells age and why this makes us grow old. Nat Rev Mol Cell Biol. 2007;8(9):703–713. doi: 10.1038/nrm2241